Abstract:In vivo imaging of bacterial infection models enables noninvasive and temporal analysis of individuals, enhancing our understanding of infectious disease pathogenesis. Conventional in vivo imaging methods for bacterial infection models involve the insertion of the bacterial luciferase LuxCDABE into the bacterial genome, followed by imaging using an expensive ultrasensitive charge-coupled device (CCD) camera. However, issues such as limited light penetration into the body and lack of versatility have been encountered. We focused on near-infrared (NIR) light, which penetrates the body effectively, and attempted to establish an in vivo imaging method to evaluate the number of lung-colonizing bacteria during the course of bacterial pneumonia. This was achieved by employing a novel versatile system that combines plasmid-expressing firefly luciferase bacteria, NIR substrate, and an inexpensive, scientific complementary metal-oxide semiconductor (sCMOS) camera. The D-luciferin derivative "TokeOni," capable of emitting NIR bioluminescence, was utilized in a mouse lung infection model of Acinetobacter baumannii, an opportunistic pathogen that causes pneumonia and is a concern due to drug resistance. TokeOni exhibited the highest sensitivity in detecting bacteria colonizing the mouse lungs compared with other detection systems such as LuxCDABE, enabling the monitoring of changes in bacterial numbers over time and the assessment of antimicrobial agent efficacy. Additionally, it was effective in detecting A. baumannii clinical isolates and Klebsiella pneumoniae. The results of this study are expected to be used in the analysis of animal models of infectious diseases for assessing the efficacy of therapeutic agents and understanding disease pathogenesis. Importance: Conventional animal models of infectious diseases have traditionally relied upon average assessments involving numerous individuals, meaning they do not directly reflect changes in the pathology of an individual. Moreover, in recent years, ethical concerns have resulted in the demand to reduce the number of animals used in such models. Although in vivo imaging offers an effective approach for longitudinally evaluating the pathogenesis of infectious diseases in individual animals, a standardized method has not yet been established. To our knowledge, this study is the first to develop a highly versatile in vivo pulmonary bacterial quantification system utilizing near-infrared luminescence, plasmid-mediated expression of firefly luciferase in bacteria, and a scientific complementary metal-oxide semiconductor camera. Our research holds promise as a useful tool for assessing the efficacy of therapeutic drugs and pathogenesis of infectious diseases.

Whole-Body Imaging of Bacteria Expressing Mkate 2 Fluorescence

In Vivo Optical Imaging of Bacterial Infection and Antibiotic Response in Intact Nude Mice

In vivo long-term investigation of tumor bearing mKate2 by an in-house fluorescence molecular imaging system

In vivo imaging of Lactococcus lactis, Lactobacillus plantarum and Escherichia coli expressing infrared fluorescent protein in mice

Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice.

Universal membrane-labeling combined with expression of Katushka far-red fluorescent protein enables non-invasive dynamic and longitudinal quantitative 3D dual-color fluorescent imaging of multiple bacterial strains in mouse intestine

Near-infrared in vivo imaging system for dynamic visualization of lung-colonizing bacteria in mouse pneumonia

Establishment of an Mkate2-Expressing Cell Line for Non-Invasive Real-Time Breast Cancer in Vivo Imaging

Imaging tuberculosis with endogenous β-lactamase reporter enzyme fluorescence in live mice

In vivo Labeling and Intravital Imaging of Bacterial Infection using a Near‐infrared Fluorescent D‐Amino Acid Probe

Whole-animal Imaging of Bacterial Infection Using Endoscopic Excitation of Β-Lactamase (Blac)-Specific Fluorogenic Probe

Bacteria-Based Live Vehicle for In Vivo Bioluminescence Imaging

Bacteria-Based Live Vehicle for <i>In Vivo</i> Bioluminescence Imaging

Intravital Excitation Increases Detection Sensitivity For Pulmonary Tuberculosis By Whole-Body Imaging With -Lactamase Reporter Enzyme Fluorescence

Optical Imaging of Bacterial Infection in Living Mice Using A Fluorescent Near-Infrared Molecular Probe

Encoding with a Fluorescence-Activating and Absorption-Shifting Tag Generates Living Bacterial Probes for Mammalian Microbiota Imaging.

Compact Whole-Body Fluorescent Imaging of Nude Mice Bearing Egfp Expressing Tumor

Bioluminescent Bacterial Imaging in Vivo

A novel mouse model of soft-tissue infection using bioluminescence imaging allows noninvasive, real-time monitoring of bacterial growth

In Vivo Fluorescence Reflectance Imaging with Subcutaneous Mouse Tumor Models.

A Novel Universal Nano-Luciferase-involved Reporter System for Long-Term Probing Food-Borne Probiotics and Pathogenic Bacteria in Mice by in Situ Bioluminescence Imaging